IBDEI1QT ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,31192,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,31192,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,31193,0)
 ;;=L40.9^^190^1932^255
 ;;^UTILITY(U,$J,358.3,31193,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31193,1,3,0)
 ;;=3^Psoriasis,Unspec
 ;;^UTILITY(U,$J,358.3,31193,1,4,0)
 ;;=4^L40.9
 ;;^UTILITY(U,$J,358.3,31193,2)
 ;;=^5009171
 ;;^UTILITY(U,$J,358.3,31194,0)
 ;;=L50.9^^190^1932^287
 ;;^UTILITY(U,$J,358.3,31194,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31194,1,3,0)
 ;;=3^Urticaria,Unspec
 ;;^UTILITY(U,$J,358.3,31194,1,4,0)
 ;;=4^L50.9
 ;;^UTILITY(U,$J,358.3,31194,2)
 ;;=^5009204
 ;;^UTILITY(U,$J,358.3,31195,0)
 ;;=L53.8^^190^1932^147
 ;;^UTILITY(U,$J,358.3,31195,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31195,1,3,0)
 ;;=3^Erythematous Conditions NEC
 ;;^UTILITY(U,$J,358.3,31195,1,4,0)
 ;;=4^L53.8
 ;;^UTILITY(U,$J,358.3,31195,2)
 ;;=^88044
 ;;^UTILITY(U,$J,358.3,31196,0)
 ;;=L53.9^^190^1932^146
 ;;^UTILITY(U,$J,358.3,31196,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31196,1,3,0)
 ;;=3^Erythematous Condition,Unspec
 ;;^UTILITY(U,$J,358.3,31196,1,4,0)
 ;;=4^L53.9
 ;;^UTILITY(U,$J,358.3,31196,2)
 ;;=^5009210
 ;;^UTILITY(U,$J,358.3,31197,0)
 ;;=L54.^^190^1932^145
 ;;^UTILITY(U,$J,358.3,31197,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31197,1,3,0)
 ;;=3^Erythema in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,31197,1,4,0)
 ;;=4^L54.
 ;;^UTILITY(U,$J,358.3,31197,2)
 ;;=^5009211
 ;;^UTILITY(U,$J,358.3,31198,0)
 ;;=L56.0^^190^1932^139
 ;;^UTILITY(U,$J,358.3,31198,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31198,1,3,0)
 ;;=3^Drug Phototoxic Response
 ;;^UTILITY(U,$J,358.3,31198,1,4,0)
 ;;=4^L56.0
 ;;^UTILITY(U,$J,358.3,31198,2)
 ;;=^5009214
 ;;^UTILITY(U,$J,358.3,31199,0)
 ;;=L56.1^^190^1932^138
 ;;^UTILITY(U,$J,358.3,31199,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31199,1,3,0)
 ;;=3^Drug Photoallergic Response
 ;;^UTILITY(U,$J,358.3,31199,1,4,0)
 ;;=4^L56.1
 ;;^UTILITY(U,$J,358.3,31199,2)
 ;;=^5009215
 ;;^UTILITY(U,$J,358.3,31200,0)
 ;;=L56.2^^190^1932^237
 ;;^UTILITY(U,$J,358.3,31200,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31200,1,3,0)
 ;;=3^Photocontact Dermatitis
 ;;^UTILITY(U,$J,358.3,31200,1,4,0)
 ;;=4^L56.2
 ;;^UTILITY(U,$J,358.3,31200,2)
 ;;=^5009216
 ;;^UTILITY(U,$J,358.3,31201,0)
 ;;=L56.3^^190^1932^269
 ;;^UTILITY(U,$J,358.3,31201,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31201,1,3,0)
 ;;=3^Solar Urticaria
 ;;^UTILITY(U,$J,358.3,31201,1,4,0)
 ;;=4^L56.3
 ;;^UTILITY(U,$J,358.3,31201,2)
 ;;=^5009217
 ;;^UTILITY(U,$J,358.3,31202,0)
 ;;=L57.0^^190^1932^12
 ;;^UTILITY(U,$J,358.3,31202,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31202,1,3,0)
 ;;=3^Actinic Keratosis
 ;;^UTILITY(U,$J,358.3,31202,1,4,0)
 ;;=4^L57.0
 ;;^UTILITY(U,$J,358.3,31202,2)
 ;;=^66900
 ;;^UTILITY(U,$J,358.3,31203,0)
 ;;=L60.0^^190^1932^162
 ;;^UTILITY(U,$J,358.3,31203,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31203,1,3,0)
 ;;=3^Ingrowing Nail
 ;;^UTILITY(U,$J,358.3,31203,1,4,0)
 ;;=4^L60.0
 ;;^UTILITY(U,$J,358.3,31203,2)
 ;;=^5009234
 ;;^UTILITY(U,$J,358.3,31204,0)
 ;;=L60.1^^190^1932^235
 ;;^UTILITY(U,$J,358.3,31204,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31204,1,3,0)
 ;;=3^Onycholysis
 ;;^UTILITY(U,$J,358.3,31204,1,4,0)
 ;;=4^L60.1
 ;;^UTILITY(U,$J,358.3,31204,2)
 ;;=^186837
 ;;^UTILITY(U,$J,358.3,31205,0)
 ;;=L60.2^^190^1932^234
 ;;^UTILITY(U,$J,358.3,31205,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31205,1,3,0)
 ;;=3^Onychogryphosis
 ;;^UTILITY(U,$J,358.3,31205,1,4,0)
 ;;=4^L60.2
 ;;^UTILITY(U,$J,358.3,31205,2)
 ;;=^5009235
 ;;^UTILITY(U,$J,358.3,31206,0)
 ;;=L60.3^^190^1932^171
